TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test
Welcome to DNA Labs UAE, your trusted genetic testing laboratory. Today, we will be discussing the TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test.
Test Name: TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test
Components
- Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for TPP1 Gene Spinocerebellar Ataxia Type 7, autosomal recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TPP1 Gene Spinocerebellar Ataxia Type 7, autosomal recessive.
Test Details
The TPP1 gene is associated with a condition called spinocerebellar ataxia type 7 (SCA7). SCA7 is a progressive neurodegenerative disorder that affects the cerebellum, a part of the brain involved in coordinating movement. Autosomal recessive inheritance means that both copies of the TPP1 gene must be mutated in order for the condition to develop. This means that an individual must inherit a mutated copy of the gene from both parents in order to be affected by SCA7.
NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the TPP1 gene, to identify any mutations or variations that may be present. This type of testing can help confirm a diagnosis of SCA7 and can also be used for carrier testing in individuals with a family history of the condition.
Overall, the TPP1 gene spinocerebellar ataxia type 7 autosomal recessive NGS genetic test is a genetic test that analyzes the TPP1 gene for mutations associated with autosomal recessive SCA7 using next-generation sequencing technology.
Test Name | TPP1 Gene Spinocerebellar ataxia type 7 autosomal recessive Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TPP1 Gene Spinocerebellar ataxia type 7, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TPP1 Gene Spinocerebellar ataxia type 7, autosomal recessive |
Test Details |
The TPP1 gene is associated with a condition called spinocerebellar ataxia type 7 (SCA7). SCA7 is a progressive neurodegenerative disorder that affects the cerebellum, a part of the brain involved in coordinating movement. Autosomal recessive inheritance means that both copies of the TPP1 gene must be mutated in order for the condition to develop. This means that an individual must inherit a mutated copy of the gene from both parents in order to be affected by SCA7. NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the TPP1 gene, to identify any mutations or variations that may be present. This type of testing can help confirm a diagnosis of SCA7 and can also be used for carrier testing in individuals with a family history of the condition. Overall, the TPP1 gene spinocerebellar ataxia type 7 autosomal recessive NGS genetic test is a genetic test that analyzes the TPP1 gene for mutations associated with autosomal recessive SCA7 using next-generation sequencing technology. |